Regulation of larval protein synthesis by dMyc. (A) The hsflp-out system was used to induce ubiquitous UAS-dMyc expression in third instar larvae. Control larvae expressed UAS-GFP alone. 24 h following transgene induction, larvae were inverted and incubated in Schneider's media+puromycin (5 µg/ml) for 40 min. Equal amounts of whole larval protein extracts were then analyzed by western blotting. Left, western blot with anti-puromycin antibody. Right, Ponceau S staining showing total protein levels. Genotypes: control=ywhsflp122/+; +/+; act>CD2>GAL4, UAS-GFP/+, dMyc=ywhsflp122/+; UAS-dMyc/+; act>CD2>GAL4, UAS-GFP/+. (B) UAS-dMyc clones were generated in larval fat body cells using the flp-out system. Larvae were inverted and incubated in Schneider's media+puromycin (5 µg/ml) for 40 min. Tissues were then immunostained with and anti-puromycin antibody. The nuclear GFP-marked cells overexpressing UAS-dMyc (arrows) show increased puromycin incorporation compared to surrounding non-GFP marked wild-type cells (arrowheads). Genotype: =ywhsflp122/+; UAS-dMyc/+; act>CD2>GAL4, UAS-GFP/+. (C) UAS-GFP clones were generated in larval fat body cells using the flp-out system. Larvae were inverted and incubated in Schneider's media+puromycin (5 µg/ml) for 40 min. Tissues were then immunostained with an anti-puromycin antibody. The GFP-marked cells overexpressing (arrows) show no change in puromycin incorporation compared to surrounding non-GFP marked wild-type cells (arrowheads). Genotype: ywhsflp122/+; +/+; act>CD2>GAL4, UAS-GFP/+.